EX-23.1 4 anip-2024x1231xexx231.htm EX-23.1
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of ANI Pharmaceuticals, Inc. on Form S-3 (No. 333-261731) and Form S-8 (Nos. 333-260662, 333-264511, 333-272860, and 333-280785) of our reports dated February 28, 2025, on our audits of the financial statements as of December 31, 2024 and 2023 and for each of the years in the three-year period ended December 31, 2024, and the effectiveness of ANI Pharmaceuticals, Inc.’s internal control over financial reporting as of December 31, 2024, which reports are included in this Annual Report on Form 10-K to be filed on or about February 28, 2025.
/s/ EisnerAmper LLP
EISNERAMPER LLP
West Palm Beach, Florida
February 28, 2025